Stay updated with breaking news from Functional Class. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Late-Breaking Data Highlight Abbott Structural Heart Transcatheter Valve Therapies• Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life• Findings demonstrate TriClip™ transcatheter edge-to-edge (TEER) repair is e...
Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life
Data presented at EuroPCR 2022 reinforce the impact of Abbott's minimally invasive heart devices on patient outcomes and quality of life Findings demonstrate...
Abbott today announced clinical study data supporting its TriClip and Navitor heart valve treatment technologies.
Initial Data from REDWOOD-HCM OLE, the Open Label Extension Study of Aficamten, to be Presented at Heart Failure 2022 on May 23, 2022 Continued Launch...